SCHEMBL4408034

SCHEMBL4408034

CCN(C(=O)c1ccccn1)c1nnc[nH]1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.41
GAA P10253 2/20 0.40
OPRD1 P41143 1/20 0.40
KCNH2 Q12809 1/20 0.40
CES2 O00748 1/20 0.39
CES1 P23141 1/20 0.39
NPC1 O15118 3/20 0.38
RAB9A P51151 3/20 0.38
HSD17B10 Q99714 2/20 0.38
TP53 P04637 1/20 0.38
LMNA P02545 3/20 0.38
L3MBTL1 Q9Y468 2/20 0.38
NAPRT Q6XQN6 1/20 0.38
P4HTM Q9NXG6 1/20 0.38
GRM4 Q14833 1/20 0.38
CTNNB1 P35222 1/20 0.38
WNT3A P56704 1/20 0.38
HPGD P15428 2/20 0.38
HTT P42858 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3754547 0.77 ALDH1A1 (0.52) ALDH1A1GAARAB9ALMNASMN1; SMN2
SCHEMBL986289 0.77 HDAC6 (0.43) ALDH1A1GAACES2CES1NPC1
SCHEMBL15153061 0.73 NPC1 (0.41) ALDH1A1GAACES2CES1NPC1
SCHEMBL30975214 0.72 ALDH1A1 (0.58) ALDH1A1GAAOPRD1KCNH2CES2
SCHEMBL8405203 0.72 ALDH1A1 (0.58) ALDH1A1GAAOPRD1KCNH2CES2
SCHEMBL16741186 0.70 ALDH1A1 (0.53) ALDH1A1GAAOPRD1KCNH2CES2
SCHEMBL746435 0.70 MLYCD (0.39) ALDH1A1GAAOPRD1TP53HPGD
SCHEMBL10416948 0.70 GRM1 (0.45) ALDH1A1GAAOPRD1KCNH2CES2
Hydrochloric Acid SCHEMBL30476602 0.69 ALDH1A1 (0.52) ALDH1A1GAAOPRD1KCNH2CES2
SCHEMBL30975242 0.67 KDM4E (0.52) ALDH1A1GAAOPRD1KCNH2CES2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090042905-A1 TRIAZOLE DERIVATIVES AS LIGANDS OF G-PROTEIN COUPLED RECEPTORS AETERNA ZENTARIS GMBH (DE) 2009-02-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090042905-A1 TRIAZOLE DERIVATIVES AS LIGANDS OF G-PROTEIN COUPLED RECEPTORS GPR3, GRK3, GPR88 ALDH1A1 2149/4885GAA 3696/4885OPRD1 323/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.